Brief: Ascelia Pharma Q4 Operating Loss Widens To SEK 39.2 Mln

Ascelia Pharma AB

10/02/2022 07:25

Feb 10 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * QUARTERLY REPORT Q4 2021: STRONG DATA FOR ORVIGLANCE
VERSUS. A
GADOLINIUM CONTRAST AGENT
    * Q4 OPERATING RESULT OF SEK -39.2M (SEK -27.9M)
    * Q4 EARNINGS PER SHARE OF SEK -1.01 (SEK -1.25)
    * Q4 CASH FLOW FROM OPERATIONS OF SEK -32.2M (SEK -27.6M)

Source text for Eikon:  ID:nMFNb0rWdV 
Further company coverage:  ACELP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))